BSE filing, BSE: 542123. Summary written from the filing by ALFA Finder's alert engine.
The Phosphate Company Ltd: key numbers
- Share price
- ₹135.00
- Market cap
- ₹48.70 Cr
- Revenue (annual)
- ₹145.6 Cr
- Net profit (annual)
- ₹4.52 Cr
- P/E (TTM)
- 11.6×Sector 9.7×
- Promoter holding
- 69.73%-0.69% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from The Phosphate Company Ltd
All →The Phosphate Company Other Announcement
The company filed its quarterly shareholding pattern for the quarter ended September 30, 2026. This disclosure is a routine compliance filing per SEBI Regulation 31.
The Phosphate Company Promoter Buying: ₹0.13 Cr
Promoter group entities Devendra Finvest and Chintamani Holdings acquired 8,791 shares of The Phosphate Company Ltd from the open market, increasing their aggregate stake by 0.24%.
- Value
- ₹0.13 Cr
- Promoter stake change
- +0.24%
The Phosphate Company Annual General Meeting
The Phosphate Company Ltd announced voting results from its AGM held on September 23, 2026. Shareholders approved a Rs. 2 per share final dividend and other routine resolutions.
- Value
- ₹0.72 Cr
The Phosphate Company Annual General Meeting
The Phosphate Company filed the scrutiniser report and voting results of its 77th AGM held 23 September 2026. All resolutions, including the final dividend, were passed by requisite majority.
The Phosphate Company Promoter Buying: ₹0.23 Cr
Phosphate Company promoter group bought 15,611 shares on BSE for Rs. 0.23 Crore. Devendra Finvest and Chintamani Holdings raised their stakes through open-market purchases.
- Value
- ₹0.23 Cr
- Promoter stake change
- +0.43%
The Phosphate Company Dividend
The Phosphate Company Ltd held its 77th Annual General Meeting on September 23, 2026. All resolutions, including a final dividend of Rs. 2 per share, were passed.
Other credit rating announcements
All →Epigral Credit Rating
CRISIL revised Epigral's ratings to CRISIL AA/Stable (long-term) and CRISIL A1+ (short-term) on its bank facilities. The action covers Rs.1,050 Crore of rated bank loan facilities.
Mankind Pharma Credit Rating
CRISIL reaffirmed Mankind Pharma's AA+ rating on Rs.2,500 Crore of NCDs and withdrew ratings on Rs.2,500 Crore NCDs and Rs.1,500 Crore commercial paper. The rating action is dated October 29, 2026.
Lloyds Metals & Energy Credit Rating
Crisil Ratings reaffirmed Lloyds Metals' bank facilities at AA/Stable and A1+, with bank limits enhanced to ₹17,112 crore. It assigned AA/Stable to ₹2,400 crore and ₹1,550 crore of NCDs.
Ram Ratna Wires Credit Rating
CARE Ratings assigned and reaffirmed Ram Ratna Wires' bank facility ratings at CARE A-; Positive / CARE A2+ and revised outlook from Stable to Positive. The long-term bank facilities total Rs.1,046.45 Crore, with several facilities enhanced.
Adani Ports & Special Economic Zone Credit Rating
Fitch Ratings affirmed Adani Ports' Long-Term Foreign-Currency IDR and unsecured notes at 'BBB-' with a Stable outlook. The affirmation keeps the existing rating unchanged.
Capri Global Capital Credit Rating
India Ratings affirmed CGCL's credit rating at IND AA- with Positive outlook. A new Rs. 500 Cr bank loan facility was also assigned the same rating.